Purchase Order HHSN273201700157P
Award Date 8/21/17
Potential Completion Date 10/6/17
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Butner, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $86,760.00 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract provides a NovaSeq 6000 sequencing service agreement with an estimated completion date of June 28, 2025. There is no set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the NIH, CDC, USDA, and VA...
- This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The award, valued at $135,908.52, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute awarded Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and analytics, a firm fixed-price purchase order contract worth $803,760.00 for a NovaSeq 6000 sequencing system. The contract was awarded on December 7, 2017 with a completion date of December 31, 2020. Illumina has previously provided a range of sequencing instruments, reagents, and...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for a one-year comprehensive plan to provide HiSeq 2000, cBOT, and MiSeq systems. The $100,884 contract does not include a set-aside provision. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents that have been utilized across various federal agencies, including the Centers...
- This is a $863,550.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Illumina, Inc. for the provision of lab equipment, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and other consumables. Illumina is a manufacturer and provider of genomic sequencing and analysis solutions. The award has no set-aside designation. Illumina has a history of providing...
- This is a $164,633.80 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously held prime contracts and subcontracts with various federal agencies...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
- This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
- This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. The order is for $75,832.10 and does not have a set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and consumables, is providing products and services to support genomic sequencing and analysis, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and bioinformatics support....
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) to Illumina, Inc. for $17,598.18. The contract does not have a set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying consumables and support services, to support genomic sequencing and analysis for research and diagnostic applications across several...